نتایج جستجو برای: p gp inhibition

تعداد نتایج: 1574865  

Journal: :The American journal of tropical medicine and hygiene 2012
Enoche F Oga Shuichi Sekine Yoshihisa Shitara Toshiharu Horie

Antimalarials are widely used in African and Southeast Asian countries, where they are combined with other drugs for the treatment of concurrent ailments. The potential for P-glycoprotein (P-gp)-mediated drug-drug interactions (DDIs) between antimalarials and P-gp substrates was examined using a Caco-2 cell-based model. Selected antimalarials were initially screened for their interaction with P...

Journal: :Molecules 2017
Saikat Dewanjee Tarun K Dua Niloy Bhattacharjee Anup Das Moumita Gangopadhyay Ritu Khanra Swarnalata Joardar Muhammad Riaz Vincenzo De Feo Muhammad Zia-Ul-Haq

Multidrug resistance (MDR) is regarded as one of the bottlenecks of successful clinical treatment for numerous chemotherapeutic agents. Multiple key regulators are alleged to be responsible for MDR and making the treatment regimens ineffective. In this review, we discuss MDR in relation to P-glycoprotein (P-gp) and its down-regulation by natural bioactive molecules. P-gp, a unique ATP-dependent...

Journal: :the iranian journal of pharmaceutical research 0
abdolhamid parsa 1- department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. 2- student research committee, shahid beheshti university of medical sciences, tehran, iran. roonak saadati department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. zahra abbasian department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. saeed azad aramaki clinical laboratory section, khatamolanbia hospital, tehran, iran. simin dadashzadeh 1- department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. 2- pharmaceutical sciences research center, shahid beheshti university of medical sciences, tehran, iran.

etoposide, a widely used anticancer drug, exhibits low and variable oral bioavailability mainly because of being substrate for the efflux transporter, p-glycoprotein (p-gp). therefore, the present study was aimed to investigate the effect of d-α-tocopherol polyethylene glycol 1000 succinate (tpgs) and peg 400 as p-gp inhibitors on the intestinal absorption of etoposide. everted sacs of rat smal...

Etoposide, a widely used anticancer drug, exhibits low and variable oral bioavailability mainly because of being substrate for the efflux transporter, P-glycoprotein (P-gp). Therefore, the present study was aimed to investigate the effect of D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) and PEG 400 as P-gp inhibitors on the intestinal absorption of etoposide. Everted sacs of rat smal...

2018
Guo-Rong He Xiao-Kun Lin Yong-Biao Wang Cong-De Chen

Dexmedetomidine (DEX) a type of the anaesthetic that has been widely used in anaesthesia and intensive care. However, whether DEX affects the pharmacokinetics of drugs remains elusive. As hepatic P‑glycoprotein (P‑gp) serves a critical role in the disposition of drugs, the present study aimed to address whether P‑gp function could be affected by DEX in vitro. In the present study, L02 cells (a ...

Journal: :The Journal of pharmacology and experimental therapeutics 2003
Akinobu Hamada Hideto Miyano Hiroshi Watanabe Hideyuki Saito

The interaction of imatinib mesilate with P-glycoprotein (P-gp) was examined using pig kidney epithelial LLC-PK1 cells versus L-MDR1 cells, which overexpress human P-gp on the apical membrane. The basal-to-apical transport of imatinib mesilate in L-MDR1 cells significantly exceeded that in the parental LLCPK1 cells. The intracellular accumulation of imatinib mesilate after its basal application...

2015
Courtney A Follit Frances K Brewer John G Wise Pia D Vogel

Failure of cancer chemotherapies is often linked to the over expression of ABC efflux transporters like the multidrug resistance P-glycoprotein (P-gp). P-gp expression in cells leads to the elimination of a variety of chemically unrelated, mostly cytotoxic compounds. Administration of chemotherapeutics during therapy frequently selects for cells that over express P-gp and are therefore capable ...

Journal: :International journal of oncology 2007
Alexander Kaszubiak Per Sonne Holm Hermann Lage

Simultaneous resistance of cancer cells to multiple cytotoxic drugs, multidrug resistance (MDR), is the major limitation to the successful chemotherapeutic treatment of disseminated neoplasms. The 'classical' MDR phenotype is conferred by MDR1/P-glycoprotein (MDR1/P-gp) that is expressed in almost 50% of human cancers. Recent developments in the use of small interfering RNAs for specific inhibi...

Journal: :JAMA 2004
A Michael Lincoff Neal S Kleiman Dean J Kereiakes Frederick Feit John A Bittl J Daniel Jackman Ian J Sarembock David J Cohen Douglas Spriggs Ramin Ebrahimi Gadi Keren Jeffrey Carr Eric A Cohen Amadeo Betriu Walter Desmet Wolfgang Rutsch Robert G Wilcox Pim J de Feyter Alec Vahanian Eric J Topol

CONTEXT In the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial, bivalirudin with provisional glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibition was found to be noninferior to heparin plus planned Gp IIb/IIIa blockade in the prevention of acute ischemic end points and was associated with significantly less bleeding by 30 days after percutaneous coronary int...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید